95041 ⎘
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems; Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
APYRASE INHIBITORS
#2COUMARIN COMPOUNDS AND USES THEREOF
#3METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY
#4Small Molecule Agonists and Antagonists of NR2F6 Activity in Humans
#5A PROCESS FOR THE SYNTHESIS OF CARBON LABELED ORGANIC COMPOUNDS
#6MARMELIN ANALOGS AND METHODS OF USE IN CANCER TREATMENT
#7Compounds containing Si atoms for optically active devices
#8IRE-1α inhibitors
#9Glucosylceramide synthase inhibitors for the treatment of diseases
#10MARMELIN ANALOGS AND METHODS OF USE IN CANCER TREATMENT
#11IRE-1α inhibitors
#12Small molecule agonists and antagonists of NR2F6 activity in humans
#13Haptens, hapten conjugates, compositions thereof and method for their preparation and use
#14IRE-1α inhibitors
#15Sulfonate compound, photoacid generator, and resin composition for photolithography
#16MARMELIN ANALOGS AND METHODS OF USE IN CANCER TREATMENT
#17Coumarin-based compounds and related methods
#18Glucosylceramide synthase inhibitors for the treatment of diseases
#19Processes for preparing medicaments for the treatment of cardiovascular diseases and intermediates for use therein
#20MAO-B selective inhibitor compounds, pharmaceutical compositions thereof and uses thereof
#21Therapeutic compounds
#22Albicidin derivatives, their use and synthesis
#23Condensation product of theanine derivative and carboxylic acid coumarin derivative, its intermediate, preparation method and use thereof
#24Coumarin derivative
#25Use of coumarin derivatives for the preparation of drugs for treating skin diseases
#26IRE-1α inhibitors
#27Chemical enhancement by nanomaterials under X-ray irradiation
#28Therapeutic compounds
#29Methods for treating blood disorders
#30Use of coumarin derivatives for the preparation of drugs for treating skin diseases
#31Site-specific labeling of affinity tags in fusion proteins
#32Cinnamoyl inhibitors of transglutaminase
#33Functionalized phenolic compounds and polymers therefrom
#34SITE-SPECIFIC LABELING OF AFFINITY TAGS IN FUSION PROTEINS
#35Copper catalyzed cycloaddition of organic azides and 1-haloalkynes
#36Amino acid derivative
#372-SUBSTITUTED ISOFLAVONOID COMPOUNDS, MEDICAMENTS AND USES
#38DIHYDRO-ISO-CA-4 AND ANALOGUES: POTENT CYTOTOXICS, INHIBITORS OF TUBULIN POLYMERIZATION
#39Novel Compounds for Treatment of Cancer and Disorders Associated With Angiogenesis Function
#40Activators of executioner procaspases 3, 6 and 7
#41Haptens, hapten conjugates, compositions thereof and method for their preparation and use
#42Cinnamoyl inhibitors of transglutaminase
#43Haptens, hapten conjugates, compositions thereof and method for their preparation and use
#44USE OF PENTADIENOIC ACID DERIVATIVES FOR THE TREATMENT OF HYPERURICEMIA
#45Unsymmetrical aromatic ether diacids and absorbable polymers therefrom
#46Compounds and compositions for delivering active agents
#473-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof
#48Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
#49Functionalized sinapic acid and methyl sinapate
#50Methods for treating blood disorders
#51NITROSATED AND NITROSYLATED CYCLOOXYGENASE-2 INHIBITORS, COMPOSITIONS AND METHODS OF USE
#52NOVEL COMPOUNDS FOR TREATMENT OF CANCER AND DISORDERS ASSOCIATED WITH ANGIOGENESIS FUNCTION
#53SITE-SPECIFIC LABELING OF AFFINITY TAGS IN FUSION PROTEINS
#54SITE-SPECIFIC LABELING OF AFFINITY PEPTIDES IN FUSION PROTEINS
#55Haptens, hapten conjugates, compositions thereof and method for their preparation and use
#56Compound 3-(1, 1-Dimethyl-Allyl)-6-Hydroxy-Chromen-2-One and its Pharmaceutically Acceptable Salts Thereof
#57Inhibitors of human immunodeficiency virus replication
#58METHODS FOR TREATING BLOOD DISORDERS
#59Substituted cumarines, process for the production of said cumarines and composition containing said cumarines
#60Heteroaryl sulfones and sulfonamides and therapeutic uses thereof
#61Coumarin derivatives, process for their production and use thereof
#62Unsymmetrical aromatic ether diacids and absorbable polymers therefrom
#63Use of pentadienoic acid derivatives for the treatment of hyperuricemia
#64Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
#65Novel compounds for treatment of cancer and disorders associated with angiogenesis function
#66Compounds and compositions for delivering active agents
#67Site-specific labeling of affinity tags in fusion proteins
#68Sulfonate compound and fluorescent probe using the same
#69Chromene-containing compounds with anti-tubulin and vascular targeting activity
#70Site-specific labeling of affinity tags in fusion proteins
#71Compounds and compositions for delivering active agents
#72Optical data carrier comprising a cyanine dye as light-absorbent compound in the information layer
#73Coumarin derivatives, process for their production and use thereof
#74Coumarin derivatives